• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening.将低风险乳腺癌筛查途径引入国民保健制度乳腺筛查计划:实施风险分层筛查的医疗保健专业人员的观点。
Womens Health (Lond). 2021 Jan-Dec;17:17455065211009746. doi: 10.1177/17455065211009746.
2
Healthcare professionals' views following implementation of risk stratification into a national breast cancer screening programme.实施风险分层后,医疗保健专业人员对国家乳腺癌筛查计划的看法。
BMC Cancer. 2022 Oct 12;22(1):1058. doi: 10.1186/s12885-022-10134-0.
3
The feasibility of implementing risk stratification into a national breast cancer screening programme: a focus group study investigating the perspectives of healthcare personnel responsible for delivery.实施风险分层筛查纳入国家乳腺癌筛查计划的可行性:一项针对负责实施人员的观点的焦点小组研究。
BMC Womens Health. 2022 May 2;22(1):142. doi: 10.1186/s12905-022-01730-0.
4
What are the views of three key stakeholder groups on extending the breast screening interval for low-risk women? A secondary qualitative analysis.三个关键利益相关者群体对延长低危女性乳房筛查间隔的看法是什么?二次定性分析。
Health Expect. 2022 Dec;25(6):3287-3296. doi: 10.1111/hex.13637. Epub 2022 Oct 28.
5
Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders' views on a low-risk breast screening pathway.风险分层乳腺癌筛查:英国医疗保健政策决策利益相关者对低风险乳腺癌筛查途径的看法。
BMC Cancer. 2020 Jul 22;20(1):680. doi: 10.1186/s12885-020-07158-9.
6
The introduction of risk stratified screening into the NHS breast screening Programme: views from British-Pakistani women.将风险分层筛查引入国民保健制度乳房筛查计划:英国-巴基斯坦裔妇女的观点。
BMC Cancer. 2020 May 20;20(1):452. doi: 10.1186/s12885-020-06959-2.
7
Views of health professionals on risk-based breast cancer screening and its implementation in the Spanish National Health System: A qualitative discussion group study.卫生专业人员对基于风险的乳腺癌筛查及其在西班牙国家卫生系统中的实施的看法:定性讨论组研究。
PLoS One. 2022 Feb 4;17(2):e0263788. doi: 10.1371/journal.pone.0263788. eCollection 2022.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.从国际医疗保健专业人员的角度来看,女性在风险分层乳腺癌筛查和预防方面的决策。
PLoS One. 2018 Jun 1;13(6):e0197772. doi: 10.1371/journal.pone.0197772. eCollection 2018.
10
Healthcare professionals' experiences of caring for women with false-positive screening test results in the National Health Service Breast Screening Programme.医疗保健专业人员在国民保健制度乳房筛查计划中照顾假阳性筛查测试结果女性的经历。
Health Expect. 2024 Apr;27(2):e14023. doi: 10.1111/hex.14023.

引用本文的文献

1
Standardization, Education, and Resourcing: The Way Forward for Implementing Polygenic Risk Scores in Hereditary Breast and Ovarian Cancer.标准化、教育与资源配置:遗传性乳腺癌和卵巢癌中实施多基因风险评分的未来之路
Clin Transl Sci. 2025 Aug;18(8):e70323. doi: 10.1111/cts.70323.
2
Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study.来自参与MyPeBS研究的6个国家的专业人员和医疗服务提供者对基于风险的乳腺癌筛查的可接受性。
BMC Cancer. 2025 Mar 15;25(1):483. doi: 10.1186/s12885-025-13848-z.
3
Acceptability and perceptions of personalised risk-based cancer screening among health-care professionals and the general public: a systematic review and meta-analysis.医疗保健专业人员和公众对基于个性化风险的癌症筛查的可接受性和认知:一项系统评价和荟萃分析。
Lancet Public Health. 2025 Feb;10(2):e85-e96. doi: 10.1016/S2468-2667(24)00278-0.
4
Polygenic risk scores in the clinic: a systematic review of stakeholders' perspectives, attitudes, and experiences.临床中的多基因风险评分:对利益相关者观点、态度和经历的系统评价
Eur J Hum Genet. 2025 Mar;33(3):266-280. doi: 10.1038/s41431-024-01747-z. Epub 2024 Nov 23.
5
Risk-Adapted Breast Screening for Women at Low Predicted Risk of Breast Cancer: An Online Discrete Choice Experiment.基于风险的乳腺癌低预测风险女性乳房筛查:一项在线离散选择实验。
Med Decis Making. 2024 Jul;44(5):586-600. doi: 10.1177/0272989X241254828. Epub 2024 Jun 3.
6
Genomes in clinical care.临床医疗中的基因组
NPJ Genom Med. 2024 Mar 14;9(1):20. doi: 10.1038/s41525-024-00402-2.
7
"For and against" factors influencing participation in personalized breast cancer screening programs: a qualitative systematic review until March 2022.影响参与个性化乳腺癌筛查项目的“支持与反对”因素:截至2022年3月的定性系统评价
Arch Public Health. 2024 Feb 22;82(1):23. doi: 10.1186/s13690-024-01248-x.
8
Acceptability and appropriateness of a risk-tailored organised melanoma screening program: Qualitative interviews with key informants.风险定制化的有组织黑色素瘤筛查项目的可接受性和适宜性:关键信息提供者的定性访谈。
PLoS One. 2023 Dec 13;18(12):e0287591. doi: 10.1371/journal.pone.0287591. eCollection 2023.
9
Canadian Healthcare Professionals' Views and Attitudes toward Risk-Stratified Breast Cancer Screening.加拿大医疗保健专业人员对风险分层乳腺癌筛查的看法和态度。
J Pers Med. 2023 Jun 21;13(7):1027. doi: 10.3390/jpm13071027.
10
Risk-Stratified Breast Cancer Screening Incorporating a Polygenic Risk Score: A Survey of UK General Practitioners' Knowledge and Attitudes.基于多基因风险评分的风险分层乳腺癌筛查:英国全科医生知识和态度的调查。
Genes (Basel). 2023 Mar 16;14(3):732. doi: 10.3390/genes14030732.

本文引用的文献

1
The feasibility of implementing risk stratification into a national breast cancer screening programme: a focus group study investigating the perspectives of healthcare personnel responsible for delivery.实施风险分层筛查纳入国家乳腺癌筛查计划的可行性:一项针对负责实施人员的观点的焦点小组研究。
BMC Womens Health. 2022 May 2;22(1):142. doi: 10.1186/s12905-022-01730-0.
2
Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement.出版商更正:乳腺癌的个性化早期检测与预防:ENVISION共识声明。
Nat Rev Clin Oncol. 2020 Nov;17(11):716. doi: 10.1038/s41571-020-0412-0.
3
What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).风险分层筛查作为国民保健制度乳房筛查计划的一部分有哪些益处和危害?BC-predict 与常规筛查的多中心非随机比较研究方案(NCT04359420)。
BMC Cancer. 2020 Jun 18;20(1):570. doi: 10.1186/s12885-020-07054-2.
4
European women's perceptions of the implementation and organisation of risk-based breast cancer screening and prevention: a qualitative study.欧洲女性对基于风险的乳腺癌筛查和预防的实施和组织的看法:一项定性研究。
BMC Cancer. 2020 Mar 24;20(1):247. doi: 10.1186/s12885-020-06745-0.
5
Attitudes towards risk-stratified breast cancer screening among women in England: A cross-sectional survey.英格兰女性对风险分层乳腺癌筛查的态度:一项横断面调查。
J Med Screen. 2020 Sep;27(3):138-145. doi: 10.1177/0969141319883662. Epub 2019 Nov 8.
6
A systematic review and quality assessment of individualised breast cancer risk prediction models.系统评价和个体化乳腺癌风险预测模型的质量评估。
Br J Cancer. 2019 Jul;121(1):76-85. doi: 10.1038/s41416-019-0476-8. Epub 2019 May 22.
7
Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.乳腺癌的病理和分期可以通过包括乳腺密度和常见遗传变异在内的风险分层模型更好地预测。
Breast Cancer Res Treat. 2019 Jul;176(1):141-148. doi: 10.1007/s10549-019-05210-2. Epub 2019 Apr 2.
8
Health professionals' perspectives on breast cancer risk stratification: understanding evaluation of risk versus screening for disease.医疗专业人员对乳腺癌风险分层的看法:理解风险评估与疾病筛查
Public Health Rev. 2019 Feb 28;40:2. doi: 10.1186/s40985-019-0111-5. eCollection 2019.
9
Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.女性对基于个性化风险的乳腺癌筛查和预防的认知:一项国际焦点小组研究。
Psychooncology. 2019 May;28(5):1056-1062. doi: 10.1002/pon.5051. Epub 2019 Mar 25.
10
A Systematic Review of Women's Knowledge of Screening Mammography.妇女对乳房 X 光筛查知识的系统评价。
Breast. 2018 Dec;42:81-93. doi: 10.1016/j.breast.2018.08.102. Epub 2018 Aug 27.

将低风险乳腺癌筛查途径引入国民保健制度乳腺筛查计划:实施风险分层筛查的医疗保健专业人员的观点。

Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening.

机构信息

Manchester Centre for Health Psychology, Division of Psychology & Mental Health, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, MAHSC, Manchester, UK.

Nightingale and Prevent Breast Cancer Research Unit, Manchester University NHS Foundation Trust, Manchester, UK.

出版信息

Womens Health (Lond). 2021 Jan-Dec;17:17455065211009746. doi: 10.1177/17455065211009746.

DOI:10.1177/17455065211009746
PMID:33877937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8060757/
Abstract

OBJECTIVES

Proposals to stratify breast screening by breast cancer risk aim to produce a better balance of benefits to harms. Notably, risk estimation calculated from common risk factors and a polygenic risk score would enable high-risk women to benefit from more frequent screening or preventive medication. This service would also identify low-risk women who experience fewer benefits from attending, as lower grade and in situ cancers may be treated unnecessarily. It may therefore be appropriate for low-risk women to attend screening less. This study aimed to elicit views regarding implementing less frequent screening for low-risk women from healthcare professionals who implement risk-stratified screening.

METHODS

Healthcare professionals involved in the delivery of risk-stratified breast screening were invited to participate in a focus group within the screening setting in which they work or have a telephone interview. Primary care staff were also invited to provide their perspective. Three focus groups and two telephone interviews were conducted with 28 healthcare professionals. To identify patterns across the sample, data were analysed as a single dataset using reflexive thematic analysis.

RESULTS

Analysis yielded three themes: , highlighting healthcare professionals' unease and concerns towards implementing less frequent screening; , providing views on media impact on public opinion and the potential for a low-risk pathway to cause confusion and raise suspicion regarding implementation motives; and , where the practicalities of implementation are discussed.

CONCLUSIONS

Healthcare professionals broadly supported less frequent screening but had concerns about implementation. It will be essential to address concerns regarding risk estimate accuracy, healthcare professional confidence, service infrastructure and public communication prior to introducing less frequent screening for low-risk women.

摘要

目的

通过乳腺癌风险分层来提出筛查建议,旨在实现获益与危害之间更好的平衡。值得注意的是,通过常见风险因素和多基因风险评分计算出的风险估计值,将使高风险女性受益于更频繁的筛查或预防性药物治疗。这项服务还将识别出从参加筛查中获益较少的低风险女性,因为可能会不必要地治疗较低级别和原位癌。因此,低风险女性可能适当减少参加筛查的频率。本研究旨在从实施风险分层筛查的医疗保健专业人员那里征求关于对低风险女性实施较少频率筛查的意见。

方法

邀请参与实施风险分层乳腺癌筛查的医疗保健专业人员在他们工作或进行电话访谈的筛查环境中参加焦点小组。还邀请了初级保健人员提供他们的观点。对 28 名医疗保健专业人员进行了三次焦点小组和两次电话访谈。为了在样本中识别出模式,使用反思性主题分析对数据进行了单一数据集分析。

结果

分析产生了三个主题:“对减少低风险女性筛查频率的担忧”,突出了医疗保健专业人员对实施较少频率筛查的不安和担忧;“媒体对公众舆论的影响和低风险途径的潜在影响”,提供了对媒体对公众舆论的影响以及低风险途径可能导致混乱和对实施动机产生怀疑的看法;以及“实施的实际情况”,讨论了实施的实际情况。

结论

医疗保健专业人员普遍支持减少低风险女性的筛查频率,但对实施情况存在一些担忧。在为低风险女性引入较少频率的筛查之前,必须解决风险估计准确性、医疗保健专业人员信心、服务基础设施和公众沟通方面的担忧。